Assistant Professor of Neurology, and Laboratory Medicine and Pathology
Mayo Clinic College of Medicine
INSTITUTION AND LOCATION YEAR(s) FIELD OF STUDY
Honors & Accomplishments
1.International League Against Epilepsy and Epilepsia Clinical Science Prize, 2018
2.Peripheral Nerve Society: Arthur K. Asbury- Inflammatory Neuropathy Prize, 2018
3.Department of Neurology & Neurotherapeutics: Outstand Resident Award, UT Southwestern Medical Center May, 2016
4.Parkland Neurology Clinic Resident of the Year, Parkland Memorial Hospital, May, 2016
5.Department of Neurology & Neurotherapeutics: Resident Teaching Awards, UT Southwestern Medical Center May, 2016
6.Rivera-Weisberg Manuscript of the Year Award, May, 2016
7.Fred Baskin Young Investigator Research Award, May, 2015
8.Rivera-Weisberg Manuscript of the Year Award, May, 2015
Contributions to Science Publications:
1.Dubey D, Pittock SJ, McKeon A. Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability. Epilepsia. 2019 Feb;60(2):367-369.
2.Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol. 2018 Dec 21
3.Basal E, Zalewski N, Kryzer TJ, Hinson SR, Guo Y, Dubey D, Benarroch EE, Lucchinetti CF, Pittock SJ, Lennon VA, McKeon A. Paraneoplastic neuronal intermediate filament autoimmunity. Neurology. 2018 Oct 30; 91 (18)
4.Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum Toxin in Restless Legs Syndrome-A Randomized Double-Blind Placebo-Controlled Crossover Study. Toxins (Basel). 2018 Sep 29;10(10)
5.Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ. Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD. Neurology. 2018 Oct 23; 91 (17)
Assistant Professor of Neurology, Division of Neuroimmunology at the Barrow Neurological Institute, Phoenix, AZ
Clinical Assistant Professor of Neurology, University of Arizona College of Medicine, Phoenix, AZ.
Assistant Professor of Neurology, Creighton University School of Medicine, Phoenix, AZ.
Post Graduate Education
7/2016 –6/30/2018 – Combined MS and Neuroimmunology Fellowship at the University of Texas Southwestern Medical Center, Dallas, TX, USA, The Johns Hopkins University School of Medicine, Baltimore, MD and The National Institute of Health, Bethesda, MD. Supported by the National MS Society.
3/2017 –10/30/2017 – Vestibular Neurology Fellowship at the Johns Hopkins School of Medicine, Baltimore, MD.
Fellowship training areas/sub-specialties
Adult MS and related disorders (Mentor: Dr. Benjamin Greenberg and Dr. Elliot Frohman, UT Southwestern Medical Center, Dallas and Dr. Peter Calabresi, JHU, Baltimore, MD)
Pediatric MS and related disorders (Mentor: Dr. Benjamin Greenberg, UT Southwestern Medical Center, Dallas)
Vestibular Neurology (Mentor: Dr. David Zee and Dr. Amir Kheradmand, JHU, Baltimore, MD)
Neuromyelitis Optica, Transverse Myelitis and other rare neuro-immunological disorders (Obtained CRND certification) – (Mentors: Dr. Benjamin Greenberg and Dr. Michael Levy)
Autoimmune Encephalitis (Mentor: Dr. Steven Vernino UT Southwestern Medical Center, Dallas)
Neuro-rheumatology (Mentor: Dr. Julius Birnbaum, JHU, Baltimore, MD)
Neuroinflammatory disorders including chronic meningitis (Mentor: Dr. Avi Nath, NIH, Bethesda, MD)
Accepted into the NIH sponsored Clinical Training Methodology Course (CTMC) for 2018-2019
Honors / Awards
1) Young Investigator Educational travel award from ACTRIMS in Feb 2018
2) Alpha Omega Alpha society member at UT Southwestern Medical Center, Dallas, TX; elected by the medical student class of 2017 for excellence in teaching, patient care and research
3) Fred Baskin Young Investigator Award for excellence in Neuroscience, Teaching and Research in May 2016
4) Best Resident Teaching Award presented during graduation in May 2016
5) TEVA Neuroscience award from the Department of Neurology at UT Southwestern Medical Center for research, teaching, participation in academic sessions and performance in Resident In-service training examinations.
6) Gold medal from the former President of India Dr. APJ Abdul Kalam for topping the Tamilnadu Dr.MGR Medical University (university comprising 20 medical colleges in the entire state with 2500 medical students) in pharmacology.
7) Shanti Paniker Memorial gold medal for securing the highest rank in the university examination in Obstetrics-Gynecology.
8) Award of Excellence for securing the highest rank (in a class of 100) in the university examinations in Ophthalmology, Pharmacology and Anatomy.
Professor of Neurology
Chief, Division of Epilepsy
Director, Comprehensive Epilepsy Center
Director, Clinical Neurophysiology Lab(EEG)
Penn State University Hershey Medical center
Hershey, PA 17033, USA
B S Singhal oration of the Indian Academy of Neurology annual meeting.
The oration is scheduled to take place on October 4, 2019 between 11.30 to 12.30 hours. –
Director, UCL Institute of Neurology
Director, MRC Centre for Neuromuscular Diseases
UCL Institute of Neurology
National Hospital for Neurology and Neurosurgery
Queen Square, London, WC1N 3BG
Guest Professor at Medical University of Vienna
Head, Department of Neurology and Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders
Danube Hospital / Donauspital
1220 Vienna, Austria
Dr. Ikeda is Professor and Chairman of the Department of Psychiatry, and Director of Neuropsychology lab, Osaka University School of Medicine, Japan and was earlier Professor in the Department of Psychiatry and Neuropathobiology, Faculty of Life Sciences at Kumamoto University, Japan.
Having earned his Ph.D. for work in neuroimaging studies for mild Alzheimer’s disease at Osaka University, Dr. Ikeda learned basic neuropathology about dementia-related diseases at the Tokyo Institute of Psychiatry. Dr. Ikeda is interested in disease-specific care for dementia and constructed of a prefecture-wide network system of medical care for dementia across Japan. He conducted studies dementia as the chief researcher supported by the Health, Labour and Welfare Ministry of the Japanese government.
Dr. Ikeda implemented research on investigation of community-based epidemiology for dementia and establishment of the care system in rural area (the Nakayama study). Dr. Ikeda is also a leading investigator offronto-temporal dementia He is Director of International Psychogeriatric Association, Executive member of Asian Society against Dementia, and an active participant of World Federation of Neurology: Research Group of Aphasia and Cognitive Disorders.
Professor at University of Pavia Medical School, Italy
Nervous Diseases, London.
Epileptic Disorders, International Journal of Epilepsy, Epilepsy Research,
Seizure, Lancet Neurology and CNS Drugs.
of seizure disorders, clinical trial methodology and assessment of outcome in
people with epilepsy.
efficacy and effectiveness of AEDs as initial monotherapy, use of therapeutic drug
monitoring, definition of drug-refractory epilepsy.
pharmacology and epilepsy therapy.
Prof Wolfgang Grisold is a specialist for neurology and psychiatry. Since 1989, he has been chairing the department of neurology of the KFJ hospital in Vienna. The neurological department is an affiliated teaching hospital of the University of Vienna. His special interests apart from general neurology is neuromuscular disease and neurooncology, palliative care and education in neurology. He has participated in 2 EU projects on paraneoplastic syndromes and is participating in 2 ECCO- EU projects on oncologic video education.
He currently published 600 publications among them 3 books, 206 PubMed quoted publications, 330 Abstracts and presented over 1200 lectures. He has been involved in education from the point of CME and CPD (EFNS, UEMS, WFN), residency training (Austrian society of neurology and UEMS board of neurology ), board examinations (Austrian society of neurology and UEMS/EBN), patient and caregiver education and European and international department visits (UEMS/WFN). He has chaired the education committee of the EFNS from 2002 until 2007, has been the co-chair of the education committee of the WFN, where he presently chairs the teaching course committee.
He is a member of the ethics committee of the city of Vienna and a member of the highest medical council of the city of Vienna (“Landessanitätsrat”). From 2000 to 2002, he was the founding president of the Austrian Society of Neurology. He is a member of the UEMS/EBN (past president), the UEMS-EBN examination committee and past president of the EANO (European Association of neurooncology). Within ECCO he chairs ACOE (the accreditation body for CME) and is a member of the UEMS CME governance board. In the WFN he is the secretary general and treasurer. Apart from his hospital and scientific work he runs a private neurology office in Vienna, where combines clinical work with neuromuscular disease and electrophysiology.
Prof. William Carroll: The World Federation of Neurology (WFN) has been a vital and integral part of my life for 18 years. I attended my first Council of Delegates meeting in 1999 to present the Australian bid to host the 2005 World Congress of Neurology, which was decided at the London WCN in 2001. From that time, my admiration, respect, and enthusiasm for the WFN has grown. The development and achievements of the WFN have been outstanding and made possible by the selfless contributions of all involved in the WFN so that the achievements of the WFN, accomplished with limited resources, have engendered a deep respect for our organization.
I have been fortunate to have observed first-hand what I believe to be the essence of the WFN. Not only its mission, “to foster quality neurology and brain health worldwide,” but its sense of fairness and service. It is a sense that sits comfortably with a well-known Australian trait of “a fair go for all.”
The WFN is an organization with relatively limited financial resources, yet its mission is broad and seemingly endless. Its annual spending on operating costs, infrastructure, and personnel comprises almost half of its average annual income. Its permanent staff number is only 2.5 FTE, but it is ably assisted by the 140 members of its 15 committees. With member societies, the regional organizations, and the quality of successive administrations, the WFN is forging a role as a global advocate and neurology educator. The recent formation of the African Academy of Neurology and its first conference in Tunis this year, and the development of four regional training centers in Africa, two each for the francophone and anglophone regions, are testaments to WFN’s strength of commitment to this role, as is the successful biennial World Congresses of Neurology. Such achievements also bring the essential benefit of enhanced visibility of the WFN within its membership and among agencies that assist the WFN.
I regard my two terms as an elected trustee, my term as first vice president, and serving as chair of the Membership, Fundraising, and Congress committees, as well as convener of the Global Neurology Network to have been a privilege and an opportunity to contribute to the team.
Why do I seek the office of president? The reasons are many, but they distill to four principle and complementary reasons.
First, I believe in what the WFN does and that I have the skills, experience, commitment, and understanding of the needs of the WFN to continue to grow the educational programs, such as those established in Africa and elsewhere. I also believe that I possess the vision for the direction for the WFN in the next four years and beyond.
Second, underlying the WFN’s mission is the recognition of the inequality that exists in the development and delivery of neurological care and education. To further tackle these systematically and successfully, the WFN requires an order of priorities. I propose to continue to target the inequity of access to neurological care, expertise, and education by encouraging member societies and their regional organizations to assist in the preparation of an inventory of “most urgent inequalities.” It is likely that some will be common and amenable to a general formulated plan of assistance while others will be specific to a country or region and demand a more individual approach. We must develop a plan, and we should do it together.
Third, and in parallel with developing an inventory of and the plans and programs to tackle inequalities, I will be exploring the opportunities for the WFN and its member organizations to expand their association with both our two largest regional neurology organizations, the AAN and the EAN, and with global government, non-government, and regional intergovernmental organizations. These might include the European Union, the Gulf Cooperation Council, the Asia-Pacific Economic Cooperation, the Pan American Health Organization, the World Federation of Medical Education, and the WHO, to mention some.
The approach would be to develop cooperative strategies similar to the Africa initiative and the way the WFN has interacted with the WHO via the World Brain Alliance and the Global Neurology Network. It would likely require the establishment of a task force drawn from within the WFN and, where necessary, from professional expertise outside the WFN. We would seek out potential partners, evaluate the opportunities offered by each, match them to the needs inventory, and prepare an approach for those selected.
Lastly, it has been an honor to have been involved with the WFN up to now and to have been nominated for president by the Australian and New Zealand Association of Neurologists and supported by the Japanese Society of Neurologists. Please see below a list of positions held and papers written for the WFN supporting my candidature.
Content coming soon